Lakeland, Fla. — Molecular staging of melanoma can identify patients with missed micrometastatic disease, offering them the chance to receive more aggressive treatment, thus offering them the best chance of survival.
Social Vulnerability Among Individuals With Truncal-Extremity Melanomas Leads to Detriments in Care and Prognosis
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients
I Was in a Hurry, and I Was Sued
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium
AD Case Study: Topical Steroids Are Not Cutting It
Why Dermatologists Are Not Average Investors